Impact of a Physical Activity Program to Reduce Long-term Cancer-related Fatigue in Metastatic Testicular Germ Cell Tumor Patients
A legfontosabb adatok
- Ki végzi
- Centre Leon Berard
- Hol
- Franciaország12 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 236 fő, tervezett
- Kezdés
- 2025. jan. 14.
- Várható befejezés
- 2038. jan. 14.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Physical activity recommendations
- Connected activity tracker
- Physical Activity (PA) Intervention
- A regiszteradat frissítve
- 2026. március 31.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for men with metastatic testicular germ cell tumor who are about to start their first chemotherapy. It tests a one-year supervised physical activity program to reduce long-term tiredness.
- Életkor
- 18 years or older
- Nem
- Men only
- A betegség stádiuma
- Metastatic germ cell tumor of the testis (seminoma or non-seminoma), confirmed by tissue test. General condition score (PS) of 2 or less.
- Korábbi kezelés
- A first line of chemotherapy with BEP, EP or VIP must be planned.
A részvétel fő kizáró okai
- Bone or brain metastases that cause symptoms
- Nervous system spread with problems that prevent walking
- Another cancer now or before, except some skin or in situ cancers, or a cancer in complete remission for more than 3 years
- Health problems that rule out exercise, such as uncontrolled high blood pressure or heart disease
- Taking part in another physical activity study
A regiszter feltételei, szó szerint
Mind a 18 feltétel megnézéseKevesebb
Ki vehet részt
- Men ≥18 years
- With a metastatic germ cell tumor histologically confirmed (seminoma and non-seminoma)
- Who have already undergone an orchidectomy (since the 16th december, this criteria was deleted)
- Having a first line of chemotherapy planned with BEP, EP or VIP
- Having a smartphone (i.e. to connect the activity tracker)
- PS < or = 2
- Whose ability to practice an adapted physical activity (APA) has been certified by a medical certificate issued by the referring oncologist or the investigating physician
- Available and willing to participate in the study for the duration of the intervention and follow-up,
- Able to understand, read and write French,
- Affiliated with a social security scheme,
- Having dated and signed an informed consent
Ki nem vehet részt
- Concurrent participation in another study in PA
- History or coexistence of another primary cancer (apart from in situ cancer of any location and/or basal cell skin cancer and/or basal cell skin cancer and/or a cancer in complete remission for more than 3 years),
- Contraindication to physical activity (e.g. uncontrolled hypertension, uncontrolled heart disease) uncontrolled heart disease),
- Presence of symptomatic bone and/or brain metastases
- Central nervous system involvement with neurological deficits preventing walking
- Unable to be followed for medical, social, family, geographical or psychological reasons, during the entire study period,
- Deprived of liberty by judicial or administrative decision, or adults protected by law,
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
Testicular germ cell tumor (TGCT) is the most common malignancy in men between 15 and 40 years. Although TCGT survivors have a good survival prognosis, they suffer from short- and long-term sequelae such as chronic fatigue, psychological disorders, cardiovascular toxicities and second malignancies. The benefits of physical activity (PA) during treatments have been demonstrated in cancer patients to improve quality of life (QoL) and physical fitness and to reduce fatigue. However, few PA programs have been proposed to TGCT patients and their effects on sequelae have not been assessed yet. A growing body of evidence links treatment-related alteration in the gut microbiota to sequelae of cancer survivors, including fatigue and cardiovascular toxicities. Also, PA has been known as a possible modulator of the gut microbiota composition. To date, no study has been conducted to examine how the gut microbiota and its metabolites moderate the effect of PA on fatigue and other late effects in TGCT survivors. The objectives will be to assess the impact of a PA program on fatigue and other sequelae and to investigate how the gut microbiota and its metabolites moderate the associations between PA and sequelae. We will conduct a prospective, multicenter, phase III, randomized controlled trial of a one-year supervised PA program. 236 men with metastatic TGCT and eligible for a first line of chemotherapy will be randomly assigned to either PA intervention or control arm. All patients will benefit from a connected activity tracker and PA recommendations. In the intervention arm, PA will be based on supervised sessions and motivational interviews. The primary endpoint (fatigue) will be assessed at 3 years. The trial will provide novel insights into the impact of PA on fatigue and other sequelae in TGCT survivors with understanding a potential underlying mechanism of gut microbiota. This evidence will support the development of targeted PA guidelines to improve QoL and reduce sequelae in TGCT survivors.
A vizsgálat 2 csoportja
- Control groupMár használt kezelés, összehasonlításként
Kezelés: Physical activity recommendations és Connected activity tracker
- Intervention groupA vizsgált kezelés
Kezelés: Physical activity recommendations, Connected activity tracker és Physical Activity (PA) Intervention
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- A National, Multicenter, Phase III Randomized Controlled Trial to Assess the Impact of a One-year Supervised Physical Activity Program to Reduce Long-term Cancer-related Fatigue in Metastatic Testicular Germ Cell Tumor Patients
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 15.
- Publikációk
- A regiszteradat frissítve
- 2026. március 31.